These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 28052870)

  • 1. Phosphodiesterase 5 inhibition ameliorates angiotensin II-dependent hypertension and renal vascular dysfunction.
    Thieme M; Sivritas SH; Mergia E; Potthoff SA; Yang G; Hering L; Grave K; Hoch H; Rump LC; Stegbauer J
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F474-F481. PubMed ID: 28052870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased cGMP level contributes to increased contraction in arteries from hypertensive rats: role of phosphodiesterase 1.
    Giachini FR; Lima VV; Carneiro FS; Tostes RC; Webb RC
    Hypertension; 2011 Mar; 57(3):655-63. PubMed ID: 21282562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil reduces aortic endothelial dysfunction and structural damage in spontaneously hypertensive rats: Role of NO, NADPH and COX-1 pathways.
    Leal MAS; Aires R; Pandolfi T; Marques VB; Campagnaro BP; Pereira TMC; Meyrelles SS; Campos-Toimil M; Vasquez EC
    Vascul Pharmacol; 2020 Jan; 124():106601. PubMed ID: 31689530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphodiesterase 5 attenuates the vasodilatory response in renovascular hypertension.
    Stegbauer J; Friedrich S; Potthoff SA; Broekmans K; Cortese-Krott MM; Quack I; Rump LC; Koesling D; Mergia E
    PLoS One; 2013; 8(11):e80674. PubMed ID: 24260450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sildenafil Protects against Myocardial Ischemia-Reperfusion Injury Following Cardiac Arrest in a Porcine Model: Possible Role of the Renin-Angiotensin System.
    Wang G; Zhang Q; Yuan W; Wu J; Li C
    Int J Mol Sci; 2015 Nov; 16(11):27015-31. PubMed ID: 26569234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic administration of sodium nitrite prevents hypertension and protects arterial endothelial function by reducing oxidative stress in angiotensin II-infused mice.
    Ling WC; Mustafa MR; Vanhoutte PM; Murugan DD
    Vascul Pharmacol; 2018 Mar; 102():11-20. PubMed ID: 28552746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial Morphofunctional Changes Promoted by Sildenafil in Resistance Vessels in the Angiotensin II-Induced Hypertension Model.
    Dias AT; Leal MAS; Zanardo TC; Alves GM; Porto ML; Nogueira BV; Gava AL; Campagnaro BP; Pereira TMC; Meyrelles SS; Campos-Toimil M; Vasquez EC
    Curr Pharm Biotechnol; 2018; 19(6):483-494. PubMed ID: 29938618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of gomisin J from Schisandra chinensis on angiotensin II-induced hypertension via an increased nitric oxide bioavailability.
    Ye BH; Lee SJ; Choi YW; Park SY; Kim CD
    Hypertens Res; 2015 Mar; 38(3):169-77. PubMed ID: 25427681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sildenafil reduces L-NAME-induced severe hypertension and worsening of myocardial ischaemia-reperfusion damage in the rat.
    Rossoni G; Manfredi B; De Gennaro Colonna V; Berti M; Guazzi M; Berti F
    Br J Pharmacol; 2007 Mar; 150(5):567-76. PubMed ID: 17245365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the NO-Sensitive Guanylyl Cyclase 1 and 2 on Renal Blood Flow and Systemic Blood Pressure in Mice.
    Mergia E; Thieme M; Hoch H; Daniil G; Hering L; Yakoub M; Scherbaum CR; Rump LC; Koesling D; Stegbauer J
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29570672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary vasodilation by phosphodiesterase 5 inhibition is enhanced and nitric oxide independent in early pulmonary hypertension after myocardial infarction.
    van Duin RWB; Houweling B; Uitterdijk A; Duncker DJ; Merkus D
    Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H170-H179. PubMed ID: 28986358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.
    Ramseyer VD; Ortiz PA; Carretero OA; Garvin JL
    Am J Physiol Renal Physiol; 2016 Apr; 310(8):F748-F754. PubMed ID: 26887831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDE5 inhibitor efficacy is estrogen dependent in female heart disease.
    Sasaki H; Nagayama T; Blanton RM; Seo K; Zhang M; Zhu G; Lee DI; Bedja D; Hsu S; Tsukamoto O; Takashima S; Kitakaze M; Mendelsohn ME; Karas RH; Kass DA; Takimoto E
    J Clin Invest; 2014 Jun; 124(6):2464-71. PubMed ID: 24837433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II-Induced Hypertension Is Attenuated by Reduction of Sympathetic Output in NO-Sensitive Guanylyl Cyclase 1 Knockout Mice.
    Broekmans K; Stegbauer J; Potthoff SA; Russwurm M; Koesling D; Mergia E
    J Pharmacol Exp Ther; 2016 Jan; 356(1):191-9. PubMed ID: 26559126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of cGMP-dependent protein kinase I (cGKI) and PDE5 in the regulation of Ang II-induced cardiac hypertrophy and fibrosis.
    Patrucco E; Domes K; Sbroggió M; Blaich A; Schlossmann J; Desch M; Rybalkin SD; Beavo JA; Lukowski R; Hofmann F
    Proc Natl Acad Sci U S A; 2014 Sep; 111(35):12925-9. PubMed ID: 25139994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-(1-7)-induced Mas receptor activation attenuates atherosclerosis through a nitric oxide-dependent mechanism in apolipoproteinE-KO mice.
    Yang G; Istas G; Höges S; Yakoub M; Hendgen-Cotta U; Rassaf T; Rodriguez-Mateos A; Hering L; Grandoch M; Mergia E; Rump LC; Stegbauer J
    Pflugers Arch; 2018 Apr; 470(4):661-667. PubMed ID: 29352340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
    Williams J; Bogwu J; Oyekan A
    J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of phosphodiesterase 1A1 expression is associated with the development of nitrate tolerance.
    Kim D; Rybalkin SD; Pi X; Wang Y; Zhang C; Munzel T; Beavo JA; Berk BC; Yan C
    Circulation; 2001 Nov; 104(19):2338-43. PubMed ID: 11696475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.
    Stevenson KM; Edgley AJ; Bergström G; Worthy K; Kett MM; Anderson WP
    Hypertension; 2000 Nov; 36(5):839-44. PubMed ID: 11082153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.